Posted Aug. 29, 2012 at 5:23 a.m.

Premium Lock Novartis smoker's cough drug beats GSK's Advair in trial

Published: 2012-08-29 05:23:00
Updated: 2012-08-29 05:23:00

Lung disease Lung disease Image 1 of 2 · Next Image…

Patients taking Novartis's QVA149 were able to expel more air from their lungs in one second than those receiving Glaxo's best-selling Advair after 26 weeks of treatment, according to a summary of data from a trial....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 Bloomberg. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll